Charles River Laboratories | CRL - Market Capitalization


Charles River Laboratories reported $13.86B in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agilent USD 39.08B 6.43B Jun/2026
Align Technology USD 12.08B 198M Jun/2026
Bio-Rad Laboratories USD 7.87B 390M Jun/2026
Bruker USD 9.16B 3.66B Jun/2026
Cardinal Health USD 55.64B 5.92B Jun/2026
Charles River Laboratories USD 10.39B 2.54B Jun/2026
Cigna USD 72.93B 2.59B Jun/2026
Concord Medical Services Hldg CNY 117.2M 61.02M Dec/2025
CVS Health USD 132B 39.95B Jun/2026
Danaher USD 138.86B 10.4B Jun/2026
Dentsply International USD 2.13B 191M Jun/2026
Elevance Health USD 83.98B 19.68B Jun/2026
Humana USD 47.69B 26.88B Jun/2026
Illumina USD 26.71B 8.84B Jun/2026
Incyte USD 22.65B 3.92B Jun/2026
IQVIA Holdings USD 32.25B 3.62B Jun/2026
Laboratory Of America USD 22.96B 1.03B Jun/2026
Lakefront Biotherapeutics EUR 1.73B 2.64M Jun/2026
Lonza CHF 39.68B 980.61M Jun/2025
McKesson USD 88.46B 17.53B Jun/2026
Merck EUR 18.98B 27.8B Jun/2026
Mettler Toledo International USD 25.82B 278M Jun/2026
Novartis USD 240.59B 67.17B Jun/2026
Pfizer USD 138.44B 15.37B Jun/2026
Quest Diagnostics USD 23.46B 1.77B Jun/2026
Revvity USD 12.69B 2.75B Jun/2026
Thermo Fisher Scientific USD 190.65B 7.99B Jun/2026
United Therapeutics USD 23B 2.19B Jun/2026
UnitedHealth USD 377.45B 131.84B Jun/2026
Veradigm USD 525M 621M Mar/2026
Waters USD 37.24B 7.38B Jun/2026
West Pharmaceutical Services USD 25.36B 7.3B Jun/2026